AMGEN INC·4

Mar 18, 8:38 PM ET

REESE DAVID M 4

4 · AMGEN INC · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Amgen CTO David M. Reese Sells 6,022 Shares for Tax Withholding

What Happened

  • David M. Reese, EVP & Chief Technology Officer of Amgen Inc. (AMGN), had 6,022 shares disposed (withheld) to satisfy tax withholding obligations related to equity awards. The shares were recorded at $366.21 each, for a total value of $2,205,317, per the March 16, 2026 transaction reported on a Form 4 filed March 18, 2026.

Key Details

  • Transaction date and price: 2026-03-16, 6,022 shares at $366.21 each.
  • Transaction type/code: F — payment of exercise price or tax liability (shares withheld/disposed to cover taxes).
  • Total value: $2,205,317.
  • Shares owned after transaction: not specified in the filing.
  • Footnote: 744 of the shares represent Dividend Equivalents (DEs) credited to unvested Restricted Stock Units under Amgen’s equity plan and paid in shares on a one-to-one basis per the vesting schedule (with cash for any fractional share).
  • Filing timeliness: Reported on Form 4 filed 2026-03-18 for the 2026-03-16 transaction (timely).

Context

  • This was a tax-withholding/share-surrender transaction related to equity compensation (routine), not an open-market sale indicating a trading decision. Such disposals are common when companies withhold shares to satisfy payroll/tax obligations on vested awards.

Insider Transaction Report

Form 4
Period: 2026-03-16
REESE DAVID M
EVP & Chief Technology Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-03-16$366.21/sh6,022$2,205,31741,787 total
Footnotes (1)
  • [F1]These shares include 744 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ David M. Reese|2026-03-16

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT